Tradestie Institutional Equity Comparison Engine

ZJYL vs DXR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DXR Overall Edge

DXR Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Daxor Corporation Common Stock (DXR) driven by superior Valuation, Growth & Margin while ZJYL counters with relative strength in Momentum & Technical. Fundamentally, ZJYL trades at N/M Forward P/E with 2.1% operating margin (-9.7% YoY revenue) versus DXR at 64.5x Forward P/E and -5894.3% operating margin (+25.5% YoY). In options structure, ZJYL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DXR
ZJYL N/M vs DXR 64.5x Fwd P/E
Growth & Margin Winner DXR
Op Margin 2.1% vs -5894.3% ยท YoY -9.7% vs +25.5%
Momentum & Technical Winner ZJYL
1Y +1264.7% vs -38.3% ยท 52W Pos 73% vs 2%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZJYL NASDAQ
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$3.63
+3.71% 1D
Market Cap $557.2M
1M Return +74.51%
1Y Return +1264.66%
Forward P/E N/M
Unified AI Score
33.1 / 100 SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 50.0
DXR NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap $49.5M
1M Return -16.87%
1Y Return -38.29%
Forward P/E 64.5x
Unified AI Score
52.2 / 100 HOLD
Tech 52.0 Fund 59.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZJYL +1264.66% DXR -38.29% Spread: +1329.42 pp (ZJYL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZJYL TTM Op. Margin: 2.1% DXR TTM Op. Margin: -5894.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZJYL vs DXR. Trailing 12-month operating profitability (ZJYL 2.1% vs DXR -5894.3%) and valuation multiples (ZJYL N/M vs DXR 64.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZJYL (3) vs DXR (7)
Institutional Metric ZJYL DXR Criterion Row Winner
Market Capitalization Scale $557.2M $49.5M Larger Scale ZJYL
Trailing P/E Ratio Valuation 18.4x 7.7x Lower Multiple DXR
Forward P/E Ratio Valuation N/M 64.5x Lower Multiple DXR
Revenue Growth (YoY) Growth -9.7% +25.5% Higher Growth DXR
Operating Margin (TTM) Profitability 2.1% -5894.3% Higher Margin ZJYL
Net Profit Margin Profitability 5.9% 19861.4% Higher Margin DXR
Return on Equity (ROE) Capital Efficiency 4.0% 14.2% Higher ROE DXR
52-Week Range Position Momentum 73% ($0โ€“$5) 2% ($8โ€“$15) Stronger Trend ZJYL
Beta / 30D Volatility Risk Regime 14.10ฮฒ ยท 180% Vol 0.28ฮฒ ยท 32% Vol Lower Realized Risk DXR
Unified Institutional Score Composite Signal 33.1 / 100 (SELL) 52.2 / 100 (HOLD) Higher Composite DXR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZJYL vs DXR Buy Guide
ZJYL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZJYL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DXR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DXR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZJYL nor DXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.